Literature DB >> 30291437

The significance of tissue biopsy for fungi in necrotizing otitis externa.

Rani Abu Eta1,2, Haim Gavriel3,4,5, Kleid Stephen6, Ephraim Eviatar1,2, Eyal Yeheskeli1,2.   

Abstract

INTRODUCTION: The conventional treatment for necrotizing otitis externa (NOE) is prolonged anti-pseudomonas therapy, with surgical treatment in non-responsive patients. The aim of the present study is to describe the course of management of patients with non-responsive NOE undergoing hyperbaric oxygen therapy (HBOT), and to investigate the importance of tissue biopsy for fungi in this group of patients.
MATERIALS AND METHODS: A retrospective study conducted between January 2010 and December 2013 at an Otolaryngology Head and Neck Surgery Department. Included were all 52 patients with NOE referred to our Medical Centre for further treatment including HBOT.
RESULTS: Fifty-two consecutive patients, 29 men and 23 women, with a mean age of 70.6 years, were included in our study. Twenty seven (51.9%) underwent surgical debridement. No significant difference was found between the group having surgical intervention, and those who did not, with regard to sex, age, comorbidities, cranial nerve involvement or laboratory results. However, those who had surgical intervention had a statistically significant higher rate of fungal infection (P = 0.049). After completing 7 weeks of HBOT, a significantly lower WBC count was observed in the fungus-infected group (7000 vs 7.800, P = 0.03), and a tendency towards lower CRP levels in the fungus-infected group (16 vs 58, P = 0.087).
CONCLUSION: Patients with NOE should have a comprehensive surgical intervention when delayed healing is observed, because proper fungal culturing might change the course of treatment and improve prognosis. LEVEL OF EVIDENCE: 4.

Entities:  

Keywords:  Fungi; Hyperbaric oxygen therapy; Necrotizing external otitis; Prognosis; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30291437     DOI: 10.1007/s00405-018-5151-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Diffusion MR imaging features of skull base osteomyelitis compared with skull base malignancy.

Authors:  B Ozgen; K K Oguz; A Cila
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

2.  Adjuvant hyperbaric oxygen in malignant external otitis.

Authors:  J C Davis; G A Gates; C Lerner; M G Davis; J T Mader; A Dinesman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-01

Review 3.  Skull base osteomyelitis. Malignant external otitis.

Authors:  W H Slattery; D E Brackmann
Journal:  Otolaryngol Clin North Am       Date:  1996-10       Impact factor: 3.346

4.  Clinical outcome parameters for necrotizing otitis externa.

Authors:  Ayşegül Verim; Bariş Naiboğlu; Çigdem Tepe Karaca; Lütfü Seneldir; Semra Külekçi; Çağatay Oysu
Journal:  Otol Neurotol       Date:  2014-02       Impact factor: 2.311

5.  Fungal malignant external otitis.

Authors:  Yaniv Hamzany; Ethan Soudry; Michal Preis; Tuvia Hadar; Ohad Hilly; Jihad Bishara; Ben I Nageris
Journal:  J Infect       Date:  2011-01-13       Impact factor: 6.072

6.  Fungal osteomyelitis of the temporal bone: a review of reported cases.

Authors:  E Hanna; G Hughes; I Eliachar; J Wanamaker; W Tomford
Journal:  Ear Nose Throat J       Date:  1993-08       Impact factor: 1.697

7.  Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient.

Authors:  Gal Finer; David Greenberg; Eugene Leibovitz; Alberto Leiberman; Ilan Shelef; Joseph Kapelushnik
Journal:  Scand J Infect Dis       Date:  2002

Review 8.  Invasive external otitis caused by Aspergillus.

Authors:  P Phillips; G Bryce; J Shepherd; D Mintz
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

9.  Diagnosis, complications, and treatment of malignant otitis externa.

Authors:  C I Timon; T O'Dwyer
Journal:  Ir Med J       Date:  1989-02

10.  Malignant Otitis Externa Outcomes: A Study of the University HealthSystem Consortium Database.

Authors:  Jonathan L Hatch; Michael J Bauschard; Shaun A Nguyen; Paul R Lambert; Ted A Meyer; Theodore R McRackan
Journal:  Ann Otol Rhinol Laryngol       Date:  2018-07-02       Impact factor: 1.547

View more
  1 in total

1.  Predictive factors in treatment response of malignant external otitis.

Authors:  Alireza Zonnour; Abolfazl Jamshidi; Sasan Dabiri; Mehrdad Hasibi; Ardavan Tajdini; Narges Karrabi; Nasrin Yazdani
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-25       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.